<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02735395</url>
  </required_header>
  <id_info>
    <org_study_id>SISNEP/513</org_study_id>
    <nct_id>NCT02735395</nct_id>
  </id_info>
  <brief_title>Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis</brief_title>
  <official_title>Impact of Different Dosages and Time of Administration of Metronidazole and Amoxicillin in the Treatment of Generalized Chronic Periodontitis: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Guarulhos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Guarulhos</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to compare the clinical and microbiological outcomes of different
      dosages of metronidazole (MTZ) and of the duration of the systemic administration of MTZ and
      amoxicillin as adjunct to scaling and root planing (SRP) in the treatment of generalized
      chronic periodontitis (GChP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized clinical trials and systematic reviews have shown that the use of the combination
      of metronidazole (MTZ) and amoxicillin (AMX) significantly improves the benefits of the SRP
      in the treatment of subjects with periodontitis. However, the optimal dosage and interval of
      administration of these antibiotics are still unclear. Therefore, the aim of this study was
      to compare the clinical and microbiological outcomes of different dosages and duration of the
      systemic administration of the combination of MTZ and AMX as adjunct to scaling and root
      planing (SRP) in the treatment of generalized chronic periodontitis (GChP). One hundred ten
      subjects will be randomly assigned to receive SRP plus placebo, or SRP combined with 250 mg
      or 400 mg of MTZ, plus AMX (500 mg) TID, for either 7 or 14 days. Subjects will be clinically
      and microbiologically monitored up to 1 year post-therapy.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of subjects reaching ≤ 4 periodontal sites with probing depth (PD) ≥ 5 mm at 12 months</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of sites with PD ≥ 5 mm</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of sites with PD ≥ 6 mm</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of sites with PD ≥ 7 mm</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in the number of sites with PD ≥ 5 mm</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in the number of sites with PD ≥ 6 mm</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in the number of sites with PD ≥ 7 mm</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full-mouth PD</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full-mouth clinical attachment level</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of sites with bleeding on probing</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of sites with plaque accumulation</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of sites with marginal bleeding</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of headache obtained through a questionnaire of adverse effects</measure>
    <time_frame>14 days after the beginning of treatments</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of vomiting obtained through a questionnaire of adverse effects</measure>
    <time_frame>14 days after the beginning of treatments</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of diarrhea obtained through a questionnaire of adverse effects</measure>
    <time_frame>14 days after the beginning of treatments</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of metallic taste obtained through a questionnaire of adverse effects</measure>
    <time_frame>14 days after the beginning of treatments</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of nausea obtained through a questionnaire of adverse effects</measure>
    <time_frame>14 days after the beginning of treatments</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of irritability obtained through a questionnaire of adverse effects</measure>
    <time_frame>14 days after the beginning of treatments</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportions of periodontal pathogenic bacterial species</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Counts of periodontal pathogenic bacterial species</measure>
    <time_frame>Baseline, 3, 6 and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Scaling and root planing (SRP) + two placebo pills thrice a day (TID) for 14 days (control group)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MTZ 250 (7 days)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SRP + MTZ (250mg/TID) + AMX, for 7 days and placebos for another 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MTZ 400 (7 days)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SRP + MTZ (400mg/TID) + AMX, for 7 days and placebos for another 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MTZ 250 (14 days)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SRP +MTZ (250mg/TID) + AMX for 14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MTZ 400 (14 days)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SRP +MTZ (400mg/TID) + AMX for 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scaling and root planing (SRP)</intervention_name>
    <description>SRP performed in four to six appointments lasting approximately 1 h each, using manual curettes (Hu-Friedy, Chicago, IL, USA) and ultrasonic device (Cavitron Select SPC, Dentsply professional, York, PA, USA) under local anesthesia. The deep sites will be scaled throughout the first week and treatment of the entire oral cavity will be completed in 14 days.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>MTZ 250 (7 days)</arm_group_label>
    <arm_group_label>MTZ 400 (7 days)</arm_group_label>
    <arm_group_label>MTZ 250 (14 days)</arm_group_label>
    <arm_group_label>MTZ 400 (14 days)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole 250 (7 days)</intervention_name>
    <description>Subjects will intake Metronidazole 250 mg. for 7 days, starting immediately after the first session of Scaling and Root Planing.</description>
    <arm_group_label>MTZ 250 (7 days)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole 400 (7 days)</intervention_name>
    <description>Subjects will intake Metronidazole 400 mg. for 7 days, starting immediately after the first session of Scaling and Root Planing.</description>
    <arm_group_label>MTZ 400 (7 days)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole 250 (14 days)</intervention_name>
    <description>Subjects will intake Metronidazole 250 mg. for 14 days, starting immediately after the first session of Scaling and Root Planing.</description>
    <arm_group_label>MTZ 250 (14 days)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metronidazole 400 (14 days)</intervention_name>
    <description>Subjects will intake Metronidazole 400 mg. for 14 days, starting immediately after the first session of Scaling and Root Planing.</description>
    <arm_group_label>MTZ 400 (14 days)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin</intervention_name>
    <description>Subjects will intake Amoxicillin 500 mg. for 14 days, starting immediately after and the first session of Scaling and Root Planing.</description>
    <arm_group_label>MTZ 250 (7 days)</arm_group_label>
    <arm_group_label>MTZ 400 (7 days)</arm_group_label>
    <arm_group_label>MTZ 250 (14 days)</arm_group_label>
    <arm_group_label>MTZ 400 (14 days)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo 250 (7 days)</intervention_name>
    <description>Subjects will intake placebo of Metronidazole 250 mg. for 7 days, starting immediately after to intake Metronidazole 250 mg.</description>
    <arm_group_label>MTZ 250 (7 days)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo 400 (7 days)</intervention_name>
    <description>Subjects will intake placebo of Metronidazole 400 mg. for 7 days, starting immediately after to intake Metronidazole 400 mg.</description>
    <arm_group_label>MTZ 400 (7 days)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo 400 (14 days)</intervention_name>
    <description>Subjects will intake placebo of Metronidazole 400 mg. for 14 days, starting immediately after the first session of Scaling and Root Planing.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo 500</intervention_name>
    <description>Subjects will intake placebo of Amoxicillin 500 mg. for 14 days, starting immediately after the first session of Scaling and Root Planing.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥30 years of age;

          -  at least 15 teeth (excluding third molars and teeth with advanced decay indicated for
             extraction)

          -  a minimum of 6 teeth with at least one site each with probing depth (PD) and clinical
             * attachment level (CAL) ≥5 mm;

          -  at least 30% of the sites with PD and CAL ≥4 mm and bleeding on probing (BOP).

        Exclusion Criteria:

          -  pregnancy

          -  breastfeeding

          -  current smoking and former smoking within the past 5 years;

          -  systemic diseases that could affect the progression of periodontitis (e.g. diabetes,
             immunological disorders, osteoporosis);

          -  scaling and root planing an in the previous 12 months;

          -  antibiotic therapy in the previous 6 months;

          -  long-term intake of anti-inflammatory medications;

          -  need for antibiotic pre-medication for routine dental therapy;

          -  allergy to metronidazole and/or amoxicillin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magda Feres, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Guarulhos University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Guarulhos University</name>
      <address>
        <city>Guarulhos</city>
        <state>São Paulo</state>
        <zip>07023-070</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. J Clin Periodontol. 2012 Mar;39(3):284-94. doi: 10.1111/j.1600-051X.2011.01795.x. Epub 2012 Jan 4.</citation>
    <PMID>22220822</PMID>
  </reference>
  <reference>
    <citation>Carvalho LH, D'Avila GB, Leão A, Haffajee AD, Socransky SS, Feres M. Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. I. clinical results. J Clin Periodontol. 2004 Dec;31(12):1070-6.</citation>
    <PMID>15560807</PMID>
  </reference>
  <reference>
    <citation>Cionca N, Giannopoulou C, Ugolotti G, Mombelli A. Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis. J Periodontol. 2009 Mar;80(3):364-71. doi: 10.1902/jop.2009.080540 .</citation>
    <PMID>19254119</PMID>
  </reference>
  <reference>
    <citation>Feres M, Figueiredo LC, Soares GM, Faveri M. Systemic antibiotics in the treatment of periodontitis. Periodontol 2000. 2015 Feb;67(1):131-86. doi: 10.1111/prd.12075. Review.</citation>
    <PMID>25494600</PMID>
  </reference>
  <reference>
    <citation>Feres M, Soares GM, Mendes JA, Silva MP, Faveri M, Teles R, Socransky SS, Figueiredo LC. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol. 2012 Dec;39(12):1149-58. doi: 10.1111/jcpe.12004. Epub 2012 Sep 27.</citation>
    <PMID>23016867</PMID>
  </reference>
  <reference>
    <citation>Guerrero A, Griffiths GS, Nibali L, Suvan J, Moles DR, Laurell L, Tonetti MS. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol. 2005 Oct;32(10):1096-107.</citation>
    <PMID>16174275</PMID>
  </reference>
  <reference>
    <citation>Mestnik MJ, Feres M, Figueiredo LC, Soares G, Teles RP, Fermiano D, Duarte PM, Faveri M. The effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized aggressive periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol. 2012 Oct;39(10):955-61. doi: 10.1111/j.1600-051X.2012.01932.x. Epub 2012 Aug 6.</citation>
    <PMID>22882646</PMID>
  </reference>
  <reference>
    <citation>Mestnik MJ, Feres M, Figueiredo LC, Duarte PM, Lira EA, Faveri M. Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis. J Clin Periodontol. 2010 Apr;37(4):353-65. doi: 10.1111/j.1600-051X.2010.01538.x.</citation>
    <PMID>20447259</PMID>
  </reference>
  <reference>
    <citation>Miranda TS, Feres M, Perez-Chaparro PJ, Faveri M, Figueiredo LC, Tamashiro NS, Bastos MF, Duarte PM. Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1-year outcomes of a randomized placebo-controlled clinical trial. J Clin Periodontol. 2014 Sep;41(9):890-9. doi: 10.1111/jcpe.12282. Epub 2014 Jul 17.</citation>
    <PMID>24930639</PMID>
  </reference>
  <reference>
    <citation>Rabelo CC, Feres M, Gonçalves C, Figueiredo LC, Faveri M, Tu YK, Chambrone L. Systemic antibiotics in the treatment of aggressive periodontitis. A systematic review and a Bayesian Network meta-analysis. J Clin Periodontol. 2015 Jul;42(7):647-57. doi: 10.1111/jcpe.12427. Review.</citation>
    <PMID>26087839</PMID>
  </reference>
  <reference>
    <citation>Sgolastra F, Gatto R, Petrucci A, Monaco A. Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontol. 2012 Oct;83(10):1257-69. Epub 2012 Feb 14. Review.</citation>
    <PMID>22220767</PMID>
  </reference>
  <reference>
    <citation>Sgolastra F, Petrucci A, Gatto R, Monaco A. Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-analysis. J Periodontol. 2012 Jun;83(6):731-43. doi: 10.1902/jop.2011.110432. Epub 2011 Nov 3. Review.</citation>
    <PMID>22050545</PMID>
  </reference>
  <reference>
    <citation>Silva MP, Feres M, Sirotto TA, Soares GM, Mendes JA, Faveri M, Figueiredo LC. Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol. 2011 Sep;38(9):828-37. doi: 10.1111/j.1600-051X.2011.01763.x. Epub 2011 Jul 15.</citation>
    <PMID>21762197</PMID>
  </reference>
  <reference>
    <citation>Zandbergen D, Slot DE, Niederman R, Van der Weijden FA. The concomitant administration of systemic amoxicillin and metronidazole compared to scaling and root planing alone in treating periodontitis: =a systematic review=. BMC Oral Health. 2016 Feb 29;16:27. doi: 10.1186/s12903-015-0123-6. Review.</citation>
    <PMID>26928597</PMID>
  </reference>
  <reference>
    <citation>Zandbergen D, Slot DE, Cobb CM, Van der Weijden FA. The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review. J Periodontol. 2013 Mar;84(3):332-51. doi: 10.1902/jop.2012.120040. Epub 2012 May 21. Review.</citation>
    <PMID>22612369</PMID>
  </reference>
  <reference>
    <citation>Soares GM, Mendes JA, Silva MP, Faveri M, Teles R, Socransky SS, Wang X, Figueiredo LC, Feres M. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a secondary analysis of microbiological results from a randomized clinical trial. J Clin Periodontol. 2014 Apr;41(4):366-76.</citation>
    <PMID>24834504</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2016</study_first_submitted>
  <study_first_submitted_qc>April 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <last_update_submitted>May 17, 2017</last_update_submitted>
  <last_update_submitted_qc>May 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Guarulhos</investigator_affiliation>
    <investigator_full_name>Belén Retamal-Valdes</investigator_full_name>
    <investigator_title>DDS, MSc, PhD Student</investigator_title>
  </responsible_party>
  <keyword>Periodontal Diseases</keyword>
  <keyword>Metronidazole</keyword>
  <keyword>Amoxicillin</keyword>
  <keyword>Chronic periodontitis</keyword>
  <keyword>Root Planing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

